Manchester Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.27K Buy
+267
New +$1.78K ﹤0.01% 1020
2025
Q2
Sell
-80
Closed -$637 1233
2025
Q1
$637 Hold
80
﹤0.01% 1074
2024
Q4
$728 Buy
+80
New +$772 ﹤0.01% 1060
2024
Q3
Sell
-97
Closed -$949 1195
2024
Q2
$949 Buy
97
+51
+111% +$622 ﹤0.01% 1011
2024
Q1
$695 Buy
46
+30
+188% +$544 ﹤0.01% 914
2023
Q4
$345 Sell
16
-295
-95% -$5.44K ﹤0.01% 943
2023
Q3
$5.78K Hold
311
﹤0.01% 633
2023
Q2
$7.88K Hold
311
﹤0.01% 567
2023
Q1
$8.05K Sell
311
-933
-75% -$25K ﹤0.01% 571
2022
Q4
$29.4K Sell
1,244
-311
-20% -$8.38K ﹤0.01% 398
2022
Q3
$39K Sell
1,555
-311
-17% -$10.9K 0.01% 373
2022
Q2
$62K Hold
1,866
0.01% 351
2022
Q1
$135K Hold
1,866
0.02% 297
2021
Q4
$171K Sell
1,866
-65
-3% -$7.77K 0.02% 281
2021
Q3
$245K Sell
1,931
-63
-3% -$9.17K 0.03% 256
2021
Q2
$332K Hold
1,994
0.05% 215
2021
Q1
$362K Sell
1,994
-83
-4% -$19.3K 0.05% 192
2020
Q4
$415K Buy
2,077
+53
+3% +$10.8K 0.06% 167
2020
Q3
$444K Buy
2,024
+1,371
+210% +$290K 0.07% 150
2020
Q2
$125K Buy
653
+638
+4,253% +$112K 0.02% 281
2020
Q1
$2K Buy
+15
New +$1.75K ﹤0.01% 520
2019
Q2
Sell
-1,344
Closed -$75K 640
2019
Q1
$75K Buy
+1,344
New +$82.1K 0.01% 346

Other funds holding TDOC

Manchester Capital Management's TDOC Position: Q2 2026 in Review

Manchester Capital Management opened a new position in Teladoc Health (TDOC) in Q2 2026: 267 shares worth $2.27K. The stake represents ﹤0.01% of the portfolio and ranks #1020 among its holdings. This is a return to the name: Manchester Capital Management previously reported a position in TDOC as recently as Q1 2025.

Manchester Capital Management first reported a position in TDOC in Q1 2019 and has held it in 22 quarters since. The position peaked at $444K in Q3 2020. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Manchester Capital Management held 267 shares of Teladoc Health worth $2.27K as of Q2 2026.
  • Teladoc Health was a new Manchester Capital Management position in Q2 2026.
  • Teladoc Health made up ﹤0.01% of Manchester Capital Management's portfolio in Q2 2026, its #1020 holding.
  • Manchester Capital Management first reported a position in Teladoc Health in Q1 2019 and has held it in 22 quarters since.
  • Manchester Capital Management's Teladoc Health position peaked at $444K in Q3 2020.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.